VIVA Biotech HoldingsVIVA Biotech Holdings - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Alternative companies in the rating industry group for VIVA Biotech Holdings are shown. This dashboard contains a Q&A table for VIVA Biotech Holdings. This ESG score for VIVA Biotech Holdings represents its transparency towards the UN Sustainable Development Goals.

VIVA Biotech Holdings in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 4.8, social score of 6.4 and governance score of 4.0.

SDG Transparency Score for VIVA Biotech Holdings 
Low
0 - 3

5.1

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for VIVA Biotech Holdings 
4.8

Environmental

6.4

Social

4.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
958Provectus Biopharmaceuticals Inc
5.2
High
958Vectura Group Services Ltd
5.2
High
999VIVA Biotech Holdings
5.1
High
999Aequus Pharmaceuticals Inc
5.1
High
999BioRestorative Therapies Inc
5.1
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does VIVA Biotech Holdings have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose current and historical energy intensity?

LockedSign up for free to unlock

Does VIVA Biotech Holdings report the average age of the workforce?

LockedSign up for free to unlock

Does VIVA Biotech Holdings reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose cybersecurity risks?

LockedSign up for free to unlock

Does VIVA Biotech Holdings offer flexible work?

LockedSign up for free to unlock

Does VIVA Biotech Holdings have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does VIVA Biotech Holdings conduct supply chain audits?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does VIVA Biotech Holdings conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose water use targets?

LockedSign up for free to unlock

Does VIVA Biotech Holdings have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did VIVA Biotech Holdings have a product recall in the last two years?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose incidents of discrimination?

LockedSign up for free to unlock

Does VIVA Biotech Holdings allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has VIVA Biotech Holdings issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose parental leave metrics?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does VIVA Biotech Holdings support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does VIVA Biotech Holdings reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is VIVA Biotech Holdings involved in embryonic stem cell research?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose its waste policy?

LockedSign up for free to unlock

Does VIVA Biotech Holdings report according to TCFD requirements?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose energy use targets?

LockedSign up for free to unlock

Does VIVA Biotech Holdings disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does VIVA Biotech Holdings have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for VIVA Biotech Holdings
These potential risks are based on the size, segment and geographies of the company.

Viva Biotech Holdings, an investment holding company, provides structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide. The company provides discovery biology services, include protein expression and purification, structural biology, hit discovery, bioassay, biomolecular interaction, and pharmacokinetics; chemistry services, such as medicinal and synthetic chemistry, analytical chemistry, purification preparation, and computer-aided drug design services, as well as offers chemical technology platforms; and antibody drug research and development services, include antigen preparation, multi-species discovery, monoclonal antibodies, antibodies functional screening and identification, antibody engineering transformation, antibody characteristics, and antibody cell line engineering transformation, as well as offers technology platforms, such as hybridoma, phage and yeast display, mammalian display, VHH antibody technology, high throughput sequencing, computer-aided drug design, HDX-MS, crystal structure determination of protein, and SPR technology. It also provides cell lines, crystal structures, GPCR proteins, antibodies, and proteins. In addition, the company offers contract development and manufacturing services for small molecule active pharmaceutical ingredients (APIs) and intermediates; and trades in APIs, intermediates, and formulations, as well as equity for service. Further, it provides research service; laboratory rental services; and project management and bidding services, as well as sells compounds. The company was incorporated in 2008 and is headquartered in Shanghai, China.

Sorry!

Failed to process!